15689618 · Active · incorporated 2 years, 5 months ago · Oxford
Biotech Biotech & Life Sciences Drug Discovery Healthcare Series A
Biotechnology company developing antibody-based therapies to treat autoimmune diseases by targeting pathogenic T cells.
Re-Aim Therapeutics is a private limited company registered at Companies House under number 15689618, incorporated on 29 April 2024, with a registered office in Oxford. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 26 filings for this company, including 2 funding rounds. Its most recent round closed in October 2025, raising £7m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 2 | Oct 2025 | £7m | £32.50 |
| Round 1 | Mar 2025 | £348k | £25.00 |
Showing the 11 most recent of 26 filings.
See the complete cap table with every shareholder, founder tags, dilution across 3 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.